ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,37%
Bitcoin
65 959,20
-1,20%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Aeolus Pharmaceuticals Inc (CE) (AOLS)

  7. Aeolus Pharmaceuticals Inc (CE) (AOLS) Actualités

AOLS

Aeolus Pharmaceuticals (CE) (AOLS)

Aeolus Pharmaceuticals Inc (CE)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:AOLS
DateHeureSourceTitreSymboleSociété
22/12/201722h53Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
14/08/201723h09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
24/03/201716h51Edgar (US Regulatory)Current Report Filing (8-k)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
14/02/201717h17Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
30/01/201723h06Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
30/12/201622h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
20/12/201623h28Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
20/12/201623h25Edgar (US Regulatory)Annual Report (10-k)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
16/05/201623h09Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
19/04/201623h10Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
23/03/201621h49Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
16/02/201612h01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
12/02/201622h32Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
18/12/201512h05Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
15/12/201521h24Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
17/02/201522h32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
01/07/201413h30MarketwiredAeolus Announces Additional Data Demonstrating Efficacy of AEOL 10150 as a Medical Countermeasure Against Exposure to Nerve A...USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
18/06/201416h39MarketwiredAeolus Announces Publication of Data Demonstrating Efficacy of AEOL 10150 in Animal CEES Model of Mustard Gas Skin ExposureUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
02/06/201422h32Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
02/06/201414h00MarketwiredAeolus Pharmateucticals to Present at LD Micro Invitational ConferenceUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
16/05/201401h03MarketwiredAeolus Announces Second Quarter Fiscal Year 2014 Financial Results and Achievements in Lung-ARS Development ProgramUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
28/03/201417h24Edgar (US Regulatory)Registration of Securities by Certain Investment Companies. Declaration of Election Rule 24f-2 Notice (24f-2nt)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
28/03/201417h24Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
14/02/201423h30MarketwiredAeolus Announces First Quarter Fiscal Year 2014 Financial ResultsUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
14/02/201423h00Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
14/02/201423h00Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
13/02/201413h30MarketwiredAeolus Announces Process Improvements and Positive 18 Month Stability Results for AEOL 10150 in New FormulationUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
10/02/201413h30MarketwiredAeolus Announces Publication of Data Demonstrating Efficacy of AEOL 10150 in Animal Model of Lung Radiation Exposure; Models ...USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
23/01/201416h52MarketwiredAeolus Receives Orphan Drug Designation for AEOL 10150 From U.S. FDAUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
23/12/201314h00MarketwiredAeolus Announces Fiscal Year 2013 Financial ResultsUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:AOLS

Dernières Valeurs Consultées

EU
EN
Bouygues
EU
ACA
Credit Agricole
EU
ML
Michelin
FTSE
UKX
FTSE 100
EU
HO
Thales
EU
BNP
BNP Paribas
EU
MC
Lvmh Moet Hennessy Louis...
EU
BEL20
Bel 20
NYSE
NKE
Nike
EU
VIV
Vivendi
EU
GLE
Societe Generale
EU
RNO
Renault
EU
SGO
Cie de SaintGobain
EU
DG
Vinci
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés